Two-Year Results of the Regain Study, a Placebo-Controlled Trial with the Non-Ergot Dopamine Agonist Piribedil as Early Treatment of Parkinson's Disease (Pd)
                        AuthID
P-000-1HM
                
    P-000-1HM
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service